Lauretta Britz
Family · Humansville, MONPI 1902901176
Payments from drug & device makers
Across 114 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$323
- Novo Nordisk$250
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$191
- Lundbeck LLC$131
- AstraZeneca$114
- Alkermes, Inc.$88
- plus $811 from 24 others
What the payments were for
- Food & beverage$1,908100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $323 |
| Novo Nordisk | 14 | $250 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $191 |
| Lundbeck LLC | 8 | $131 |
| AstraZeneca | 8 | $114 |
| Alkermes, Inc. | 6 | $88 |
| Lilly USA, LLC | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| Mylan Specialty L.p. | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Novartis | 3 | $41 |
| Almatica Pharma LLC | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $31 |
| Dexcom, Inc. | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Amgen | 2 | $26 |
| Organon | 2 | $25 |
| Bayer | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Biogen | 1 | $13 |
How this compares
$1,908 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 23 | $24,465 |
| EliquisApixaban | 26 | $20,644 |
| JanuviaSitagliptin Phosphate | 24 | $18,124 |
| OzempicSemaglutide | 11 | $15,965 |
| SymbicortBudesonide/Formoterol Fumarate | 38 | $13,325 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $12,087 |
| FarxigaDapagliflozin Propanediol | 16 | $9,161 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $7,750 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $6,784 |
| XareltoRivaroxaban | 15 | $6,556 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $5,864 |
| MyrbetriqMirabegron | 13 | $5,259 |
| Levemir FlexpenInsulin Detemir | 11 | $5,219 |
| Celecoxib | 114 | $5,156 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $4,895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $61 | $24,46523 claims |
| AstraZenecaSymbicort, Farxiga | $114 | $22,48654 claims |
| Novo NordiskOzempic | $250 | $15,96511 claims |
| AbbVieSynthroid | $323 | $81416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.
Other family in Humansville
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.